TJ Cradick

Company: Gene Editing Frontiers

Job title: Chief Scientific Officer, Principal Consultant

Seminars:

Panel Discussion: Ensuring Orthogonal Validation of Unintentional Edits 9:30 am

Benchmarking the benefits and limitations of key sequencing and PCR tools for determining on- and off-target editing outcomes Assessing the latest technologies for detecting on- and off-targets How do I effectively combine a range of these assays for a robust orthogonal approach? Assessing the role of patient sequencing in the clinical settingRead more

day: Conference Day Two

Editing Assays: Their Analysis and Use in Regulatory Filings 8:10 am

Combining orthogonal, complementary assays Bioinformatics analysis to demonstrate safety Integration of these studies for FDA filingsRead more

day: Conference Day One